American Express Shares Drop 12% Despite Strong Earnings and Growth Outlook

The Motley FoolThe Motley Fool
|||1 min read
Key Takeaway

American Express stock dropped 12% despite strong 2025 earnings growth and positive 2026 guidance, suggesting market concerns about credit quality and macro risks.

American Express Shares Drop 12% Despite Strong Earnings and Growth Outlook

American Express stock has declined 12 percent year-to-date in 2026, presenting a disconnect between the company's operational performance and market valuation. The payments processor reported 2025 revenue of $72.2 billion, representing 10 percent year-over-year growth, while earnings per share reached $15.38, up 15 percent when excluding one-time gains. Management's forward guidance projects continued momentum, with revenue expected to grow 9 to 10 percent and earnings per share anticipated to expand in the mid-teens range during 2026.

The company's recent refresh of its Platinum card offering is positioned as a key driver for sustaining growth trajectories across its customer base and transaction volumes. Coupled with an aggressive capital return program, American Express has demonstrated its confidence in underlying business fundamentals and cash generation capabilities. The current valuation discount relative to earnings growth may reflect investor concerns regarding credit quality in a potentially shifting economic environment.

The gap between American Express's financial performance and stock price movement suggests the market is pricing in elevated execution or macro risks. Investors evaluating entry points should weigh the company's demonstrated earnings power and strategic initiatives against broader credit cycle considerations and competitive dynamics in the payments sector.

Source: The Motley Fool

Back to newsPublished Feb 25

Related Coverage

GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
The Motley Fool

Nvidia Edges Micron as Superior AI Play Despite Stock's Underperformance

Despite Micron's 50% YTD outperformance, analysts favor Nvidia's long-term AI prospects due to superior valuation, innovation pipeline, and diversified platform offerings.

NVDAMU
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
Investing.com

D-Wave's 44% Plunge Masks Quantum Leap: Growth Story vs. Valuation Reality

D-Wave ($QBTS) fell 44% in 2026 despite strong bookings exceeding 2025 totals and $30M in major deals. Analysts see 132% upside, but 237x sales valuation remains extreme.

QBTS
GlobeNewswire Inc.

OneMain Holdings Faces Multi-State Securities Probe Over Alleged Lending Fraud

Pomerantz Law Firm investigates $OMF following multi-state lawsuit alleging deceptive lending practices. Stock tumbles 5.38% on fraud allegations.

OMF
The Motley Fool

Discount Retailers' Pullback Creates Buying Window for Value-Hunters

Ross Stores and Five Below offer attractive entry points after recent sell-offs, with both discount retailers positioned to benefit from cost-conscious consumer behavior.

FIVEROST